Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

"Choosing Wisely": Apolipoprotein E Genetic Testing for the Diagnosis of Alzheimer's Disease in Dementia Clinics.

Journal of Alzheimer's disease : JAD - 1 Jan 2020

Yang Hyun Ju, Kang Na Ri, Jung Young Eun, Kim Moon Doo, Jeong Hyun Ghang, Lee Tae Jin, Han Ji Won, Kim Ki Woong, Park Joon Hyuk

Abstract excerpt

BACKGROUND: Apolipoprotein E (APOE) ɛ4 allele carriers have an increased risk of late-onset Alzheimer's disease (AD). However, in the "Choosing Wisely" campaign for avoiding unnecessary medical tests, treatments, and procedures, APOE genetic testing is not recommended as a predictive test for AD. OBJECTIVE: The aim of this study was to investigate the potential value of APOE genetic testing in a specific clinical...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Aged, 80 and over
Share to Alzheimer Disease

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Apolipoproteins E

Share to Genetic Testing

Share to Heterozygote

Share to Mental Status and Dementia Tests

Share to Republic of Korea

Share to Risk Factors

Source

Identifiers

PMID: 32176640
DOI: 10.3233/JAD-190983

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

"Choosing Wisely": Apolipoprotein E Genetic Testing for the Diagnosis of Alzheimer's Disease in Dementia Clinics.PMID 32176640Read ↗

The National Institute on Aging/Alzheimer's Association recommendations on the application of apolipoprotein E genotyping to Alzheimer's disease.Semantic proximity Read ↗

Exceptionally low likelihood of Alzheimer’s dementia in APOE2 homozygotesSemantic proximity Read ↗

Statement on use of apolipoprotein E testing for Alzheimer disease. American College of Medical Genetics/American Society of Human Genetics Working Group on ApoE and Alzheimer disease.Semantic proximity Read ↗

Apolipoprotein E Genetic Testing in a New Age of Alzheimer Disease Clinical PracticeSemantic proximity Read ↗

Diagnosis Test Meta-Analysis for Apolipoprotein E in Alzheimer's Disease.Semantic proximity Read ↗

Genetic testing and Alzheimer disease: recommendations of the Stanford Program in Genomics, Ethics, and Society.Semantic proximity Read ↗

APOE and dementia - resequencing and genotyping in 105,597 individuals.Semantic proximity Read ↗

Exceptionally low likelihood of Alzheimer's dementia in APOE2 homozygotes from a 5,000-person neuropathological study.Semantic proximity Read ↗

Utility of the apolipoprotein E genotype in the diagnosis of Alzheimer's disease. Alzheimer's Disease Centers Consortium on Apolipoprotein E and Alzheimer's Disease.Semantic proximity Read ↗

Apolipoprotein genotype for prediction of Alzheimer's disease in older Japanese: the Hisayama Study.Semantic proximity Read ↗

Apolipoprotein E genotyping as a diagnostic adjunct for Alzheimer's disease.Semantic proximity Read ↗

Apolipoprotein E and Alzheimer's disease. A rapidly expanding field with medical and epidemiological consequences.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.